Traumatic and surgical injuries of soft tissue that involve underlying skeletal muscle remain one of the greatest challenges to tissue reconstruction for both civilians and wounded warriors1. In fact, nearly 20% of battlefield injuries also occur in the craniofacial regions of wounded warriors (head and face)2. Inclusively, extremity trauma and head and neck injuries account for >80% of combat injuries in recent conflicts2. Despite the rather well-known capacity of skeletal muscle to repair, regenerate, and remodel following injury, these more severe injuries, which involve the loss of a substantial portion of muscle tissue, are not capable of healing on their own and are referred to as Volumetric Muscle Loss (VML) injuries. By definition, VML results in permanent aesthetic and functional deficits of either the injured muscle or the muscle unit3.
Interestingly, despite the prevalence of craniofacial VML injury2,4, much of the research to date is focused on limb5,6,7,8 and trunk9,10,11 muscles, with only a handful of reports on VML injuries in craniofacial muscles12,13,14. This presents a potentially important translational research gap, as the extant literature suggests that there are significant differences in both developmental biology, as well as regenerative capacity between craniofacial and limb and trunk muscles15,16. In fact, there are more than 20 muscles on each side of the face — reflecting the fact that the craniofacial region is involved in performing many essential tasks as diverse as blinking, swallowing, and chewing15. Furthermore, even among craniofacial muscles, differences arise with respect to regenerative ability. For example, extraocular muscles appear to regenerate more rapidly than limb muscles17. In contrast, the masseter displays a slower regenerative response than the tibialis anterior (TA)18. These differences may be due, at least in part, to whether the origins of the muscles are branchiomeric or somite-derived — resulting in both different quantities of satellite cells, as well as distinct gene expression profiles of the resident satellite cell populations19. Consideration of the unique features among craniofacial muscles, as well as relative to limb and trunk muscles, may shed important mechanistic insight for improved therapeutic development of customized treatment options that address muscle-specific VML injuries. These muscle-specific differences may also explain known limitations of sheet-like muscles, such as the latissimus dorsi, as donor muscle tissue transfer options for head and neck reconstructive surgeries20,21,22.
Regardless of the location of the VML injury, there are currently no treatments that can restore full form and function. Gold standard clinical management includes autologous tissue transfer as well as rehabilitation; however, the former typically does not improve strength and can result in donor site morbidity3,23, while the latter improves range of motion, with minimal impact on functional recovery or the return of contractile strength, in the muscle1,6. For all these reasons, research is ongoing to develop more effective therapeutic approaches for the regeneration of functional muscle tissue following VML injury. A recent analysis highlighted the critical importance of preclinical studies in rat models of VML injury to advancing regenerative technology solutions for VML repair1.
As noted in prior work5,8,9,10,24,25, assessing functional recovery after VML is critical for evaluating the effectiveness of therapeutic interventions. Specifically, while wound healing and volume recovery are key features of VML repair, measuring force recovery after injury and treatment helps to shed light on the multiscale biomechanical mechanisms responsible for VML deficits, as well as those mechanisms driving functional recovery. As such, establishing a link between tissue repair, volume recovery, and enhanced muscle strength is an absolute requirement for identifying the most efficacious regenerative solutions for VML repair9.
In this regard, there are three main methods for making these functional measurements: (1) in vitro, (2) in situ, and (3) in vivo testing — with each offering its own advantages and disadvantages8. For example, in vitro testing involves the examination of isolated muscle function outside the living organism and provides an opportunity to more directly/specifically manipulate muscle stimulation with a variety of drugs and chemicals that affect muscle excitability and contraction26. Although this method allows for detailed investigations into cellular and molecular aspects of muscle function and recovery27, it removes blood supply and innervation, which limits how well it recapitulates true muscle function8,26. In situ testing assesses muscle function while the muscle is still in its natural anatomical location but isolated from the surrounding tissues25,28. While this method maintains innervation and blood supply, the separation of the muscle can still limit the applicability of findings to the in vivo environment. Additionally, and perhaps most importantly, both in situ and in vitro testing are terminal procedures that preclude longitudinal testing - which is necessary to permit tracking functional recovery over time on the same animal. In contrast, in vivo testing, which involves evaluating muscle function in its native environment, enables a more complete understanding of muscle performance in a physiological context29. In vivo studies are also the least invasive technique and can be performed repeatedly over the time course of a study29. Using percutaneous electrical nerve stimulation, one can collect functional measurements in specific muscles while leaving tendons, vasculature, and innervation intact30. These longitudinal assessments can provide insights into subtle, yet important, changes occurring during different stages of healing in the same animal. This method is commonly employed in small rodent models8,31,32,33; however, it has also been used in larger animal models of pig30 and dog34.
There are currently three published studies on the assessment of functional recovery following craniofacial VML injuries. Rodriguez et al. report on a method for repairing a craniofacial VML injury model in the ovine zygomaticus major muscle. Their method details an in situ testing protocol that can only be implemented at the terminal study time point, and thus, does not permit longitudinal assessment within a single animal13. Kim et al. describe a method for the use of nanomembrane electronics to track continuous electromyogram data of mouse mastication following a VML injury. They reported significantly lower signal from injured mice compared to control, however, they also noted that motion artifacts affected signal analysis and that the mice would occasionally try to scratch off the circuit. Additionally, athymic, nude mice were used to allow secure attachment of the nanomembrane to the skin, which currently prevents wider utilization of this method in more commonly used (and cost-effective) animal models12. Finally, Zhao et al. describe a critically sized VML defect in the mouse masseter, which impairs nutrition in the animals, as reflected in significantly decreased body weight gain, as a functional outcome14. With these studies in mind, this article describes a versatile and minimally invasive method for the in vivo longitudinal assessment of contractile function in the rat jaw before and after a VML injury via stimulation of the trigeminal nerve with subcutaneous electrodes. As the test runs through a series of increasing simulation frequencies (20-200 Hz), a transducer measures the generated force of the muscle. These measurements can allow for the determination of muscle stiffness and maximal tetanus, among others. The protocol below is designed to assess functional recovery of ipsilateral bite force following a traumatic VML injury and, as such, also includes a protocol for the surgical creation of a validated VML injury. This method can be easily implemented on a wide variety of rats and mice — and, with appropriate equipment modifications, is applicable to larger animal models and VML injuries as well30.